Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David T Barkan

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Antimicrobial Agents and Chemotherapy|June 9, 2016
In Vitro Characterization of Human Cytomegalovirus-Targeting Therapeutic Monoclonal Antibodies LJP538 and LJP539Hetalkumar D Patel, Pavel Nikitin, Thomas Gesner, et al.
Journal of the American Chemical Society|April 2, 2022
Donor-Acceptor Pyridinium Salts for Photo-Induced Electron-Transfer-Driven Modification of Tryptophan in Peptides, Proteins, and Proteomes Using Visible LightCaleb R Hoopes, Francisco J Garcia, Akash M Sarkar, et al.
Nucleic Acids Research|November 25, 2010
ModBase, a database of annotated comparative protein structure models, and associated resourcesUrsula Pieper, Benjamin M Webb, David T Barkan, et al.
Antimicrobial Agents and Chemotherapy|August 1, 2018
Mode of Action of the Monobactam LYS228 and Mechanisms Decreasing <i>In Vitro</i> Susceptibility in Escherichia coli and Klebsiella pneumoniaeCharles R Dean, David T Barkan, Alun Bermingham, et al.
Clinical Therapeutics|September 7, 2018
The Safety and Antiviral Activity of BZF961 with or without Ritonavir in Patients Infected with Hepatitis C Virus: A Randomized, Multicenter TrialEric Lawitz, Mohamed Bidair, Thomas Marbury, et al.
Journal of Medicinal Chemistry|September 27, 2024
Identification of Potent, Broad-Spectrum Coronavirus Main Protease Inhibitors for Pandemic PreparednessDavid T Barkan, Keira Garland, Lei Zhang, et al.
Npj Drug Discovery|July 1, 2026
Preclinical characterization of EGT710, an oral non-peptidomimetic reversible covalent SARS-CoV-2 main protease inhibitorStephanie A Moquin, Suresh B Lakshminarayana, Kamal Kumar Balavenkatraman, et al.
Science Translational Medicine|February 4, 2021
NITD-688, a pan-serotype inhibitor of the dengue virus NS4B protein, shows favorable pharmacokinetics and efficacy in preclinical animal modelsStephanie A Moquin, Oliver Simon, Ratna Karuna, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Antimicrobial Agents and Chemotherapy|June 9, 2016
In Vitro Characterization of Human Cytomegalovirus-Targeting Therapeutic Monoclonal Antibodies LJP538 and LJP539Hetalkumar D Patel, Pavel Nikitin, Thomas Gesner, et al.
Journal of the American Chemical Society|April 2, 2022
Donor-Acceptor Pyridinium Salts for Photo-Induced Electron-Transfer-Driven Modification of Tryptophan in Peptides, Proteins, and Proteomes Using Visible LightCaleb R Hoopes, Francisco J Garcia, Akash M Sarkar, et al.
Nucleic Acids Research|November 25, 2010
ModBase, a database of annotated comparative protein structure models, and associated resourcesUrsula Pieper, Benjamin M Webb, David T Barkan, et al.
Antimicrobial Agents and Chemotherapy|August 1, 2018
Mode of Action of the Monobactam LYS228 and Mechanisms Decreasing <i>In Vitro</i> Susceptibility in Escherichia coli and Klebsiella pneumoniaeCharles R Dean, David T Barkan, Alun Bermingham, et al.
Clinical Therapeutics|September 7, 2018
The Safety and Antiviral Activity of BZF961 with or without Ritonavir in Patients Infected with Hepatitis C Virus: A Randomized, Multicenter TrialEric Lawitz, Mohamed Bidair, Thomas Marbury, et al.
Journal of Medicinal Chemistry|September 27, 2024
Identification of Potent, Broad-Spectrum Coronavirus Main Protease Inhibitors for Pandemic PreparednessDavid T Barkan, Keira Garland, Lei Zhang, et al.
Npj Drug Discovery|July 1, 2026
Preclinical characterization of EGT710, an oral non-peptidomimetic reversible covalent SARS-CoV-2 main protease inhibitorStephanie A Moquin, Suresh B Lakshminarayana, Kamal Kumar Balavenkatraman, et al.
Science Translational Medicine|February 4, 2021
NITD-688, a pan-serotype inhibitor of the dengue virus NS4B protein, shows favorable pharmacokinetics and efficacy in preclinical animal modelsStephanie A Moquin, Oliver Simon, Ratna Karuna, et al.
Pageof 2